SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Hi Tech Pharmacal Co Inc – ‘10-Q’ for 7/31/12 – ‘EX-101.DEF’

On:  Monday, 9/10/12, at 12:17pm ET   ·   For:  7/31/12   ·   Accession #:  1193125-12-386176   ·   File #:  0-20424

Previous ‘10-Q’:  ‘10-Q’ on 3/9/12 for 1/31/12   ·   Next:  ‘10-Q’ on 12/7/12 for 10/31/12   ·   Latest:  ‘10-Q’ on 3/11/14 for 1/31/14

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/10/12  Hi Tech Pharmacal Co Inc          10-Q        7/31/12   64:3.3M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    319K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
 4: EX-32       Certification -- §906 - SOA'02                      HTML     18K 
41: R1          Document and Entity Information                     HTML     38K 
31: R2          Condensed Consolidated Balance Sheets               HTML    120K 
39: R3          Condensed Consolidated Balance Sheets               HTML     39K 
                (Parenthetical)                                                  
43: R4          Condensed Consolidated Statements of Operations     HTML     94K 
                (Unaudited)                                                      
58: R5          Consolidated Statements of Comprehensive Income     HTML     34K 
                (Unaudited)                                                      
33: R6          Condensed Consolidated Statements of Cash Flows     HTML     80K 
38: R7          Basis of Presentation                               HTML     29K 
28: R8          Business                                            HTML     22K 
20: R9          Revenue Recognition                                 HTML     21K 
59: R10         Net Income Per Share                                HTML     23K 
45: R11         Accounts Receivable                                 HTML     55K 
44: R12         Inventory                                           HTML     28K 
49: R13         Property and Equipment                              HTML     33K 
50: R14         Intangible Assets                                   HTML     52K 
48: R15         Long-Term Debt                                      HTML     25K 
51: R16         Freight Expense                                     HTML     20K 
40: R17         Stock-Based Compensation                            HTML     35K 
42: R18         Product Divestitures                                HTML     22K 
47: R19         Income Taxes                                        HTML     26K 
63: R20         Contingencies and Other Matters                     HTML     47K 
54: R21         Recent Accounting Pronouncements                    HTML     28K 
35: R22         Significant Customers and Concentration of Credit   HTML     25K 
                Risk                                                             
46: R23         Fair Value Measurements                             HTML     37K 
37: R24         Segment Information                                 HTML     53K 
15: R25         Accounts Receivable (Tables)                        HTML     51K 
55: R26         Inventory (Tables)                                  HTML     26K 
60: R27         Property and Equipment (Tables)                     HTML     31K 
24: R28         Intangible Assets (Tables)                          HTML     42K 
23: R29         Stock-Based Compensation (Tables)                   HTML     29K 
26: R30         Fair Value Measurements (Tables)                    HTML     27K 
27: R31         Segment Information (Tables)                        HTML     44K 
29: R32         Net Income Per Share (Details)                      HTML     19K 
14: R33         Accounts Receivable (Details)                       HTML     28K 
52: R34         Accounts Receivable (Details 1)                     HTML     32K 
34: R35         Accounts Receivable (Details Textual)               HTML     21K 
36: R36         Inventory (Details)                                 HTML     29K 
18: R37         Property and Equipment (Details)                    HTML     34K 
62: R38         Property and Equipment (Details Textual)            HTML     29K 
11: R39         Intangible Assets (Details)                         HTML     47K 
30: R40         Intangible Assets (Details Textual)                 HTML     97K 
57: R41         Long-Term Debt (Details)                            HTML     45K 
17: R42         Freight Expense (Details)                           HTML     19K 
22: R43         Stock-Based Compensation (Details)                  HTML     26K 
25: R44         Stock-Based Compensation (Details Textual)          HTML     42K 
32: R45         Product Divestitures (Details)                      HTML     34K 
13: R46         Income Taxes (Details)                              HTML     25K 
19: R47         Contingencies and Other Matters (Details)           HTML     65K 
12: R48         Significant Customers and Concentration of Credit   HTML     25K 
                Risk (Details)                                                   
56: R49         Fair Value Measurements (Details)                   HTML     23K 
16: R50         Fair Value Measurements (Details Textual)           HTML     20K 
53: R51         Segment Information (Details)                       HTML     35K 
61: XML         IDEA XML File -- Filing Summary                      XML     91K 
21: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    456K 
 5: EX-101.INS  XBRL Instance -- hitk-20120731                       XML    686K 
 7: EX-101.CAL  XBRL Calculations -- hitk-20120731_cal               XML    118K 
 8: EX-101.DEF  XBRL Definitions -- hitk-20120731_def                XML    233K 
 9: EX-101.LAB  XBRL Labels -- hitk-20120731_lab                     XML    722K 
10: EX-101.PRE  XBRL Presentations -- hitk-20120731_pre              XML    484K 
 6: EX-101.SCH  XBRL Schema -- hitk-20120731                         XSD    141K 
64: ZIP         XBRL Zipped Folder -- 0001193125-12-386176-xbrl      Zip     82K 


‘EX-101.DEF’   —   XBRL Definitions — hitk-20120731_def


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL document created by RR Donnelley Tagger version 10.0.0.199; Copyright (C) RR Donnelley -->
<!-- Based on XBRL 2.1 -->
<link:linkbase xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef xlink:type="simple" xlink:href="hitk-20120731.xsd#AccountsReceivableDetails1" roleURI="http://www.hitechpharm.com/role/AccountsReceivableDetails1"/>
<link:roleRef xlink:type="simple" xlink:href="hitk-20120731.xsd#PropertyAndEquipmentDetails" roleURI="http://www.hitechpharm.com/role/PropertyAndEquipmentDetails"/>
<link:roleRef xlink:type="simple" xlink:href="hitk-20120731.xsd#IntangibleAssetsDetails" roleURI="http://www.hitechpharm.com/role/IntangibleAssetsDetails"/>
<link:roleRef xlink:type="simple" xlink:href="hitk-20120731.xsd#IntangibleAssetsTextual" roleURI="http://www.hitechpharm.com/role/IntangibleAssetsTextual"/>
<link:roleRef xlink:type="simple" xlink:href="hitk-20120731.xsd#LongTermDebtDetails" roleURI="http://www.hitechpharm.com/role/LongTermDebtDetails"/>
<link:roleRef xlink:type="simple" xlink:href="hitk-20120731.xsd#StockBasedCompensationDetails" roleURI="http://www.hitechpharm.com/role/StockBasedCompensationDetails"/>
<link:roleRef xlink:type="simple" xlink:href="hitk-20120731.xsd#ContingenciesAndOtherMattersDetails" roleURI="http://www.hitechpharm.com/role/ContingenciesAndOtherMattersDetails"/>
<link:roleRef xlink:type="simple" xlink:href="hitk-20120731.xsd#SignificantCustomersAndConcentrationOfCreditRiskDetails" roleURI="http://www.hitechpharm.com/role/SignificantCustomersAndConcentrationOfCreditRiskDetails"/>
<link:roleRef xlink:type="simple" xlink:href="hitk-20120731.xsd#SegmentInformationDetails" roleURI="http://www.hitechpharm.com/role/SegmentInformationDetails"/>
<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/AccountsReceivableDetails1" xlink:title="06051 - Disclosure - Accounts Receivable (Details 1)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" order="1"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/AccountsReceivableDetails1" xlink:title="06051 - Disclosure - Accounts Receivable (Details 1)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ReceivablesBillingStatusDomain" xlink:label="us-gaap_ReceivablesBillingStatusDomain"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_AccountsReceivableChargebackMember" xlink:label="hitk_AccountsReceivableChargebackMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_AccountsReceivableSalesDiscountMember" xlink:label="hitk_AccountsReceivableSalesDiscountMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_AccountsReceivableReturnsMember" xlink:label="hitk_AccountsReceivableReturnsMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" xlink:to="us-gaap_ReceivablesBillingStatusDomain" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivablesBillingStatusDomain" xlink:to="hitk_AccountsReceivableChargebackMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivablesBillingStatusDomain" xlink:to="hitk_AccountsReceivableSalesDiscountMember" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivablesBillingStatusDomain" xlink:to="hitk_AccountsReceivableReturnsMember" order="3"/>
</link:definitionLink>
<!-- Hypercube Definition (All) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/AccountsReceivableDetails1" xlink:title="06051 - Disclosure - Accounts Receivable (Details 1)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
</link:definitionLink>
<!-- Inheritance for Line Items: us-gaap:AccountsNotesAndLoansReceivableLineItems -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/AccountsReceivableDetails1" xlink:title="06051 - Disclosure - Accounts Receivable (Details 1)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:label="us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ValuationAllowancesAndReservesCurrentProvision" xlink:label="hitk_ValuationAllowancesAndReservesCurrentProvision"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:label="us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="hitk_ValuationAllowancesAndReservesCurrentProvision" order="3"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" order="4"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/AccountsReceivableDetails1" xlink:title="06051 - Disclosure - Accounts Receivable (Details 1)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ReceivablesBillingStatusDomain" xlink:label="us-gaap_ReceivablesBillingStatusDomain"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" xlink:to="us-gaap_ReceivablesBillingStatusDomain" order="1"/>
</link:definitionLink>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/PropertyAndEquipmentDetails" xlink:title="0607 - Disclosure - Property and Equipment (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/PropertyAndEquipmentDetails" xlink:title="0607 - Disclosure - Property and Equipment (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember" xlink:label="us-gaap_LandBuildingsAndImprovementsMember"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TransportationEquipmentMember" xlink:label="us-gaap_TransportationEquipmentMember"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LandBuildingsAndImprovementsMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_TransportationEquipmentMember" order="3"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="4"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="5"/>
</link:definitionLink>
<!-- Hypercube Definition (All) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/PropertyAndEquipmentDetails" xlink:title="0607 - Disclosure - Property and Equipment (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
</link:definitionLink>
<!-- Inheritance for Line Items: us-gaap:PropertyPlantAndEquipmentLineItems -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/PropertyAndEquipmentDetails" xlink:title="0607 - Disclosure - Property and Equipment (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="4"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/PropertyAndEquipmentDetails" xlink:title="0607 - Disclosure - Property and Equipment (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="1"/>
</link:definitionLink>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsDetails" xlink:title="0608 - Disclosure - Intangible Assets (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsDetails" xlink:title="0608 - Disclosure - Intangible Assets (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_TussicapsIntangibleAssetMember" xlink:label="hitk_TussicapsIntangibleAssetMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_EcrIntangibleAssetsMember" xlink:label="hitk_EcrIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_MagoxIntangibleAssetsMember" xlink:label="hitk_MagoxIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ClobetasolIntangibleAssetMember" xlink:label="hitk_ClobetasolIntangibleAssetMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_OrbivanAndZolvitIntangibleAssetsMember" xlink:label="hitk_OrbivanAndZolvitIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_AtleyPharmaIntangibleAssetsMember" xlink:label="hitk_AtleyPharmaIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_SinusBusterIntangibleAssetMember" xlink:label="hitk_SinusBusterIntangibleAssetMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ZolpimistIntangibleAssetsMember" xlink:label="hitk_ZolpimistIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ZostrixIntangibleAssetsMember" xlink:label="hitk_ZostrixIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_KvkLicenseIntangibleAssetsMember" xlink:label="hitk_KvkLicenseIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_MidlothianIntangibleAssetsMember" xlink:label="hitk_MidlothianIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_VosolAndVosolHcIntangibleAssetsMember" xlink:label="hitk_VosolAndVosolHcIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_PartneredAndaIntangibleAssetMember" xlink:label="hitk_PartneredAndaIntangibleAssetMember"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_TussicapsIntangibleAssetMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_EcrIntangibleAssetsMember" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_MagoxIntangibleAssetsMember" order="3"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_ClobetasolIntangibleAssetMember" order="4"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_OrbivanAndZolvitIntangibleAssetsMember" order="5"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_AtleyPharmaIntangibleAssetsMember" order="6"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_SinusBusterIntangibleAssetMember" order="7"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_ZolpimistIntangibleAssetsMember" order="8"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_ZostrixIntangibleAssetsMember" order="9"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_KvkLicenseIntangibleAssetsMember" order="10"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_MidlothianIntangibleAssetsMember" order="11"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_VosolAndVosolHcIntangibleAssetsMember" order="12"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_PartneredAndaIntangibleAssetMember" order="13"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_OtherIntangibleAssetsMember" order="14"/>
</link:definitionLink>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsDetails" xlink:title="0608 - Disclosure - Intangible Assets (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_RangeAxis" order="2"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsDetails" xlink:title="0608 - Disclosure - Intangible Assets (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="2"/>
</link:definitionLink>
<!-- Hypercube Definition (All) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsDetails" xlink:title="0608 - Disclosure - Intangible Assets (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="3" xbrldt:closed="true" xbrldt:contextElement="segment"/>
</link:definitionLink>
<!-- Inheritance for Line Items: us-gaap:FiniteLivedIntangibleAssetsLineItems -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsDetails" xlink:title="0608 - Disclosure - Intangible Assets (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_NetFiniteLivedIntangibleAssetsAbstract" xlink:label="hitk_NetFiniteLivedIntangibleAssetsAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="3"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsDetails" xlink:title="0608 - Disclosure - Intangible Assets (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsDetails" xlink:title="0608 - Disclosure - Intangible Assets (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="2"/>
</link:definitionLink>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsTextual" xlink:title="06081 - Disclosure - Intangible Assets (Details Textual)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ChemicalAxis" xlink:label="hitk_ChemicalAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="hitk_ChemicalAxis" order="1"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsTextual" xlink:title="06081 - Disclosure - Intangible Assets (Details Textual)">
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ChemicalAxis" xlink:label="hitk_ChemicalAxis"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ChemicalDomain" xlink:label="hitk_ChemicalDomain"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_DexbrompheniramineMaleateMember" xlink:label="hitk_DexbrompheniramineMaleateMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_PseudoephedrineSulfateMember" xlink:label="hitk_PseudoephedrineSulfateMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="hitk_ChemicalAxis" xlink:to="hitk_ChemicalDomain" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hitk_ChemicalDomain" xlink:to="hitk_DexbrompheniramineMaleateMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hitk_ChemicalDomain" xlink:to="hitk_PseudoephedrineSulfateMember" order="2"/>
</link:definitionLink>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsTextual" xlink:title="06081 - Disclosure - Intangible Assets (Details Textual)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="2"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsTextual" xlink:title="06081 - Disclosure - Intangible Assets (Details Textual)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_AtleyPharmaIntangibleAssetsMember" xlink:label="hitk_AtleyPharmaIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_OrbivanAndZolvitIntangibleAssetsMember" xlink:label="hitk_OrbivanAndZolvitIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_OrbivanAndCodeineIntangibleAssetsMember" xlink:label="hitk_OrbivanAndCodeineIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_KvkLicenseIntangibleAssetsMember" xlink:label="hitk_KvkLicenseIntangibleAssetsMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_TussicapsIntangibleAssetMember" xlink:label="hitk_TussicapsIntangibleAssetMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_SinusBusterIntangibleAssetMember" xlink:label="hitk_SinusBusterIntangibleAssetMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_PartneredAndaIntangibleAssetMember" xlink:label="hitk_PartneredAndaIntangibleAssetMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_MidlothianIntangibleAssetsMember" xlink:label="hitk_MidlothianIntangibleAssetsMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_AtleyPharmaIntangibleAssetsMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_OrbivanAndZolvitIntangibleAssetsMember" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_OrbivanAndCodeineIntangibleAssetsMember" order="3"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_KvkLicenseIntangibleAssetsMember" order="4"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_TussicapsIntangibleAssetMember" order="5"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_SinusBusterIntangibleAssetMember" order="6"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_PartneredAndaIntangibleAssetMember" order="7"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="hitk_MidlothianIntangibleAssetsMember" order="8"/>
</link:definitionLink>
<!-- Hypercube Definition (All) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsTextual" xlink:title="06081 - Disclosure - Intangible Assets (Details Textual)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="3" xbrldt:closed="true" xbrldt:contextElement="segment"/>
</link:definitionLink>
<!-- Inheritance for Line Items: us-gaap:BusinessAcquisitionLineItems -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsTextual" xlink:title="06081 - Disclosure - Intangible Assets (Details Textual)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_IntangibleAssetsTextualAbstract" xlink:label="hitk_IntangibleAssetsTextualAbstract"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_CashPaidForAcquiringMarketingAndDistributionRights" xlink:label="hitk_CashPaidForAcquiringMarketingAndDistributionRights"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_AcquiredFiniteLivedIntangiblePurchasePriceQuarterlyRepaymentAmount" xlink:label="hitk_AcquiredFiniteLivedIntangiblePurchasePriceQuarterlyRepaymentAmount"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_NonCashOrPartNonCashAcquisitionInventoryAcquiredTwo" xlink:label="hitk_NonCashOrPartNonCashAcquisitionInventoryAcquiredTwo"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_AdditionalAmountPaidForAcquiringRights" xlink:label="hitk_AdditionalAmountPaidForAcquiringRights"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_PaymentOfAdditionalAmountForAcquiringRightsTimeLimit" xlink:label="hitk_PaymentOfAdditionalAmountForAcquiringRightsTimeLimit"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidRoyalties" xlink:label="us-gaap_PrepaidRoyalties"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ExtendedReleaseTablets" xlink:label="hitk_ExtendedReleaseTablets"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_RefundReceived" xlink:label="hitk_RefundReceived"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetAmount" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetAmount"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_RefundsReceivableContingency" xlink:label="hitk_RefundsReceivableContingency"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_AdjustmentOfPreliminaryContingentLiability" xlink:label="hitk_AdjustmentOfPreliminaryContingentLiability"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ManufacturingAgreementToManufactureAndSupplyProductsYears" xlink:label="hitk_ManufacturingAgreementToManufactureAndSupplyProductsYears"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_PurchasePriceAndInterestInIntellectualProperty" xlink:label="hitk_PurchasePriceAndInterestInIntellectualProperty"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_PurchasePriceAndInterestPayableInInstallmentsTerm" xlink:label="hitk_PurchasePriceAndInterestPayableInInstallmentsTerm"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_CollaborationAgreementBetweenPartiesToOwnEqualPercentageInPurchaseOfProduct" xlink:label="hitk_CollaborationAgreementBetweenPartiesToOwnEqualPercentageInPurchaseOfProduct"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_CollaborationAgreementBetweenPartiesToOwnEqualPercentageInDevelopmentCost" xlink:label="hitk_CollaborationAgreementBetweenPartiesToOwnEqualPercentageInDevelopmentCost"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ProfitSharingAgreementInPercentageBetweenParties" xlink:label="hitk_ProfitSharingAgreementInPercentageBetweenParties"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_InitialPaymentByCompany" xlink:label="hitk_InitialPaymentByCompany"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EscrowDeposit" xlink:label="us-gaap_EscrowDeposit"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_RoyaltyOnNetSalesValue" xlink:label="hitk_RoyaltyOnNetSalesValue"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_NetSalesRoyaltyPercentage" xlink:label="hitk_NetSalesRoyaltyPercentage"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_RoyaltyOnNetSalesTimePeriod" xlink:label="hitk_RoyaltyOnNetSalesTimePeriod"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_CashPaidForAcquiringMarketingAndDistributionRights" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_AcquiredFiniteLivedIntangiblePurchasePriceQuarterlyRepaymentAmount" order="3"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_NonCashOrPartNonCashAcquisitionInventoryAcquiredTwo" order="4"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_AdditionalAmountPaidForAcquiringRights" order="5"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_PaymentOfAdditionalAmountForAcquiringRightsTimeLimit" order="6"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PrepaidRoyalties" order="7"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_ExtendedReleaseTablets" order="8"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_RefundReceived" order="9"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetAmount" order="10"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_RefundsReceivableContingency" order="11"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_AdjustmentOfPreliminaryContingentLiability" order="12"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" order="13"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_LiabilitiesCurrent" order="14"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_ManufacturingAgreementToManufactureAndSupplyProductsYears" order="15"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_PurchasePriceAndInterestInIntellectualProperty" order="16"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_PurchasePriceAndInterestPayableInInstallmentsTerm" order="17"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_CollaborationAgreementBetweenPartiesToOwnEqualPercentageInPurchaseOfProduct" order="18"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_CollaborationAgreementBetweenPartiesToOwnEqualPercentageInDevelopmentCost" order="19"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_ProfitSharingAgreementInPercentageBetweenParties" order="20"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_InitialPaymentByCompany" order="21"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_EscrowDeposit" order="22"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_RoyaltyOnNetSalesValue" order="23"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_NetSalesRoyaltyPercentage" order="24"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hitk_RoyaltyOnNetSalesTimePeriod" order="25"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsTextual" xlink:title="06081 - Disclosure - Intangible Assets (Details Textual)">
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ChemicalAxis" xlink:label="hitk_ChemicalAxis"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ChemicalDomain" xlink:label="hitk_ChemicalDomain"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="hitk_ChemicalAxis" xlink:to="hitk_ChemicalDomain" order="1"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/IntangibleAssetsTextual" xlink:title="06081 - Disclosure - Intangible Assets (Details Textual)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="2"/>
</link:definitionLink>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/LongTermDebtDetails" xlink:title="0609 - Disclosure - Long-Term Debt (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_CreditFacilityAxis" order="1"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/LongTermDebtDetails" xlink:title="0609 - Disclosure - Long-Term Debt (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_EquipmentFinancingAgreementMember" xlink:label="hitk_EquipmentFinancingAgreementMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="hitk_EquipmentFinancingAgreementMember" order="2"/>
</link:definitionLink>
<!-- Hypercube Definition (All) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/LongTermDebtDetails" xlink:title="0609 - Disclosure - Long-Term Debt (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
</link:definitionLink>
<!-- Inheritance for Line Items: us-gaap:LineOfCreditFacilityLineItems -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/LongTermDebtDetails" xlink:title="0609 - Disclosure - Long-Term Debt (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_LongTermDebtTextualAbstract" xlink:label="hitk_LongTermDebtTextualAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityAmountOutstanding" xlink:label="us-gaap_LineOfCreditFacilityAmountOutstanding"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_LineOfCreditFacilityDrawDownAmount" xlink:label="hitk_LineOfCreditFacilityDrawDownAmount"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_LineOfCreditFacilityAdditionalBorrowings" xlink:label="hitk_LineOfCreditFacilityAdditionalBorrowings"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPayment" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPayment"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" order="3"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityAmountOutstanding" order="4"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="hitk_LineOfCreditFacilityDrawDownAmount" order="5"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="hitk_LineOfCreditFacilityAdditionalBorrowings" order="6"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCredit" order="7"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPayment" order="8"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/LongTermDebtDetails" xlink:title="0609 - Disclosure - Long-Term Debt (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1"/>
</link:definitionLink>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/StockBasedCompensationDetails" xlink:title="0611 - Disclosure - Stock-Based Compensation (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" order="1"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/StockBasedCompensationDetails" xlink:title="0611 - Disclosure - Stock-Based Compensation (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:to="us-gaap_CostOfSalesMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="3"/>
</link:definitionLink>
<!-- Hypercube Definition (All) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/StockBasedCompensationDetails" xlink:title="0611 - Disclosure - Stock-Based Compensation (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
</link:definitionLink>
<!-- Inheritance for Line Items: us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/StockBasedCompensationDetails" xlink:title="0611 - Disclosure - Stock-Based Compensation (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="2"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/StockBasedCompensationDetails" xlink:title="0611 - Disclosure - Stock-Based Compensation (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" order="1"/>
</link:definitionLink>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/ContingenciesAndOtherMattersDetails" xlink:title="0614 - Disclosure - Contingencies and Other Matters (Details)">
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ContingenciesAndOtherMattersTable" xlink:label="hitk_ContingenciesAndOtherMattersTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hitk_ContingenciesAndOtherMattersTable" xlink:to="us-gaap_ProductOrServiceAxis" order="1"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/ContingenciesAndOtherMattersDetails" xlink:title="0614 - Disclosure - Contingencies and Other Matters (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_LodraneProductsMember" xlink:label="hitk_LodraneProductsMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductsAndServicesDomain" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="hitk_LodraneProductsMember" order="1"/>
</link:definitionLink>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/ContingenciesAndOtherMattersDetails" xlink:title="0614 - Disclosure - Contingencies and Other Matters (Details)">
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ContingenciesAndOtherMattersTable" xlink:label="hitk_ContingenciesAndOtherMattersTable"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ChemicalAxis" xlink:label="hitk_ChemicalAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hitk_ContingenciesAndOtherMattersTable" xlink:to="hitk_ChemicalAxis" order="2"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/ContingenciesAndOtherMattersDetails" xlink:title="0614 - Disclosure - Contingencies and Other Matters (Details)">
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ChemicalAxis" xlink:label="hitk_ChemicalAxis"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ChemicalDomain" xlink:label="hitk_ChemicalDomain"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_BimatoprostTopicalMember" xlink:label="hitk_BimatoprostTopicalMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_AllergansLumiganMember" xlink:label="hitk_AllergansLumiganMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_GatifloxacinOphthalmicMember" xlink:label="hitk_GatifloxacinOphthalmicMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_AllergansZymarGatifloxacinOphthalmicMember" xlink:label="hitk_AllergansZymarGatifloxacinOphthalmicMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="hitk_ChemicalAxis" xlink:to="hitk_ChemicalDomain" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hitk_ChemicalDomain" xlink:to="hitk_BimatoprostTopicalMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hitk_ChemicalDomain" xlink:to="hitk_AllergansLumiganMember" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hitk_ChemicalDomain" xlink:to="hitk_GatifloxacinOphthalmicMember" order="3"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hitk_ChemicalDomain" xlink:to="hitk_AllergansZymarGatifloxacinOphthalmicMember" order="4"/>
</link:definitionLink>
<!-- Hypercube Definition (All) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/ContingenciesAndOtherMattersDetails" xlink:title="0614 - Disclosure - Contingencies and Other Matters (Details)">
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ContingenciesAndOtherMattersTable" xlink:label="hitk_ContingenciesAndOtherMattersTable"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ContingenciesAndOtherMattersLineItems" xlink:label="hitk_ContingenciesAndOtherMattersLineItems"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="hitk_ContingenciesAndOtherMattersLineItems" xlink:to="hitk_ContingenciesAndOtherMattersTable" order="3" xbrldt:closed="true" xbrldt:contextElement="segment"/>
</link:definitionLink>
<!-- Inheritance for Line Items: hitk:ContingenciesAndOtherMattersLineItems -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/ContingenciesAndOtherMattersDetails" xlink:title="0614 - Disclosure - Contingencies and Other Matters (Details)">
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ContingenciesAndOtherMattersLineItems" xlink:label="hitk_ContingenciesAndOtherMattersLineItems"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ContingenciesAndOtherMattersTextualAbstract" xlink:label="hitk_ContingenciesAndOtherMattersTextualAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="us-gaap_SalesRevenueGoodsNet"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_PercentageOfSolutions" xlink:label="hitk_PercentageOfSolutions"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hitk_ContingenciesAndOtherMattersLineItems" xlink:to="us-gaap_SalesRevenueGoodsNet" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hitk_ContingenciesAndOtherMattersLineItems" xlink:to="hitk_PercentageOfSolutions" order="3"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/ContingenciesAndOtherMattersDetails" xlink:title="0614 - Disclosure - Contingencies and Other Matters (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductsAndServicesDomain" order="1"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/ContingenciesAndOtherMattersDetails" xlink:title="0614 - Disclosure - Contingencies and Other Matters (Details)">
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ChemicalAxis" xlink:label="hitk_ChemicalAxis"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ChemicalDomain" xlink:label="hitk_ChemicalDomain"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="hitk_ChemicalAxis" xlink:to="hitk_ChemicalDomain" order="2"/>
</link:definitionLink>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/SignificantCustomersAndConcentrationOfCreditRiskDetails" xlink:title="0616 - Disclosure - Significant Customers and Concentration of Credit Risk (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTable" xlink:label="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTable" xlink:to="us-gaap_MajorCustomersAxis" order="1"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/SignificantCustomersAndConcentrationOfCreditRiskDetails" xlink:title="0616 - Disclosure - Significant Customers and Concentration of Credit Risk (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="us-gaap_NameOfMajorCustomerDomain"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_McKessonMember" xlink:label="hitk_McKessonMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_AmerisourceBergenMember" xlink:label="hitk_AmerisourceBergenMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_CardinalHealthMember" xlink:label="hitk_CardinalHealthMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_WalgreensMember" xlink:label="hitk_WalgreensMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_NameOfMajorCustomerDomain" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="hitk_McKessonMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="hitk_AmerisourceBergenMember" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="hitk_CardinalHealthMember" order="3"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="hitk_WalgreensMember" order="4"/>
</link:definitionLink>
<!-- Hypercube Definition (All) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/SignificantCustomersAndConcentrationOfCreditRiskDetails" xlink:title="0616 - Disclosure - Significant Customers and Concentration of Credit Risk (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTable" xlink:label="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems" xlink:label="us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems" xlink:to="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
</link:definitionLink>
<!-- Inheritance for Line Items: us-gaap:HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/SignificantCustomersAndConcentrationOfCreditRiskDetails" xlink:title="0616 - Disclosure - Significant Customers and Concentration of Credit Risk (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems" xlink:label="us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_SignificantCustomersAndConcentrationOfCreditRiskTextualAbstract" xlink:label="hitk_SignificantCustomersAndConcentrationOfCreditRiskTextualAbstract"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_PercentageOfNetSalesRevenue" xlink:label="hitk_PercentageOfNetSalesRevenue"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems" xlink:to="hitk_PercentageOfNetSalesRevenue" order="2"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/SignificantCustomersAndConcentrationOfCreditRiskDetails" xlink:title="0616 - Disclosure - Significant Customers and Concentration of Credit Risk (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="us-gaap_NameOfMajorCustomerDomain"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_NameOfMajorCustomerDomain" order="1"/>
</link:definitionLink>
<!-- Hypercube Definition (Line Items to Hypercube) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/SegmentInformationDetails" xlink:title="0618 - Disclosure - Segment Information (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="1"/>
</link:definitionLink>
<!-- Domain Members -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/SegmentInformationDetails" xlink:title="0618 - Disclosure - Segment Information (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_HiTechMember" xlink:label="hitk_HiTechMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_HCPMember" xlink:label="hitk_HCPMember"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_ECRMember" xlink:label="hitk_ECRMember"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CorporateAndOtherMember" xlink:label="us-gaap_CorporateAndOtherMember"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="hitk_HiTechMember" order="1"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="hitk_HCPMember" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="hitk_ECRMember" order="3"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_CorporateAndOtherMember" order="4"/>
</link:definitionLink>
<!-- Hypercube Definition (All) -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/SegmentInformationDetails" xlink:title="0618 - Disclosure - Segment Information (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_StatementTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
</link:definitionLink>
<!-- Inheritance for Line Items: us-gaap:SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/SegmentInformationDetails" xlink:title="0618 - Disclosure - Segment Information (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
<link:loc xlink:type="locator" xlink:href="hitk-20120731.xsd#hitk_SegmentReportingOperatingProfitLossFromSegmentToConsolidatedAbstract" xlink:label="hitk_SegmentReportingOperatingProfitLossFromSegmentToConsolidatedAbstract"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_SalesRevenueNet" order="2"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="3"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_GrossProfit" order="4"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="5"/>
</link:definitionLink>
<!-- Dimension Defaults -->
<link:definitionLink xlink:type="extended" xlink:role="http://www.hitechpharm.com/role/SegmentInformationDetails" xlink:title="0618 - Disclosure - Segment Information (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain"/>
<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="1"/>
</link:definitionLink>
</link:linkbase>

Top
Filing Submission 0001193125-12-386176   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Mar. 19, 3:57:03.1am ET